MTM Regulatory Compliance & Ethical Standards 5 — Questions and Answers
Question 1: A pharmacist's MTM employer instructs staff to bill for Targeted Medication Reviews (TMRs) that were never performed. Which whistleblower protection law is MOST relevant to a pharmacist who reports this internally and then externally?
- HIPAA Privacy Rule
- False Claims Act qui tam provisions (Correct answer)
- Occupational Safety and Health Act
- Stark Law
Correct answer: False Claims Act qui tam provisions
The False Claims Act's qui tam provisions allow and protect whistleblowers who report fraud against federal health programs, entitling them to a portion of recovered funds.
Question 2: Which principle of beneficence-based ethics BEST describes the obligation to actively prevent harm to a patient during MTM, rather than just avoiding it?
- Positive beneficence (Correct answer)
- Non-maleficence
- Passive beneficence
- Utility maximization
Correct answer: Positive beneficence
Positive beneficence requires active efforts to benefit patients and prevent harm, going beyond the more passive non-maleficence standard of merely avoiding harm.
Question 3: A patient enrolled in MTM is also enrolled in a clinical trial. How should the MTM pharmacist handle medications the patient receives as a trial participant?
- Exclude trial medications entirely as they are not within MTM scope
- Document trial medications, assess interactions with regular medications, and coordinate with the trial team (Correct answer)
- Discontinue MTM enrollment until the clinical trial is completed
- Report trial participation to the plan sponsor to adjust MTM billing
Correct answer: Document trial medications, assess interactions with regular medications, and coordinate with the trial team
MTM pharmacists should document and assess all medications including investigational drugs for interactions, coordinating with the clinical trial team to ensure patient safety.
Question 4: The CMS Star Ratings program evaluates Part D plan quality, including MTM metrics. Which pharmacist behavior MOST directly contributes to improving a plan's Star Rating related to MTM?
- Completing CMRs before the plan's Star Rating measurement period ends regardless of patient need
- Ensuring high-quality CMR completion rates with documented follow-up and patient engagement (Correct answer)
- Reducing MTM enrollment to only the highest-cost patients to improve outcome metrics
- Focusing exclusively on medication adherence measures for the three statin drugs
Correct answer: Ensuring high-quality CMR completion rates with documented follow-up and patient engagement
Star Ratings reward high CMR completion rates with genuine patient engagement and documented outcomes, not just procedural completion for metric timing.
Question 5: In an MTM setting, a pharmacist realizes a patient lacks decision-making capacity. Who is the appropriate surrogate decision-maker in the absence of a designated healthcare proxy?
- The patient's physician, who automatically assumes decision-making authority
- The next of kin in accordance with state law hierarchy (typically spouse, then adult children) (Correct answer)
- The MTM pharmacist, who assumes proxy status as the treating clinician
- The insurance plan sponsor, who controls the patient's healthcare benefits
Correct answer: The next of kin in accordance with state law hierarchy (typically spouse, then adult children)
When no healthcare proxy is designated, state laws typically establish a hierarchy of surrogate decision-makers, usually beginning with the spouse or closest adult relative.
Question 6: A state board of pharmacy investigation finds a pharmacist failed to document MTM interventions per state administrative code. This violation primarily falls under which category of law?
- Federal statutory law
- State administrative/regulatory law (Correct answer)
- Federal common law
- Constitutional law
Correct answer: State administrative/regulatory law
State board of pharmacy rules and administrative codes are sources of state administrative/regulatory law governing pharmacy practice within that state.
Question 7: Which scenario BEST illustrates the ethical principle of justice in MTM program design?
- Prioritizing MTM services for patients who are most likely to adhere to recommendations
- Ensuring MTM services are equitably accessible to all eligible patients regardless of socioeconomic status (Correct answer)
- Offering enhanced MTM services to high-premium plan members
- Allocating more CMR time to patients with the highest medication costs
Correct answer: Ensuring MTM services are equitably accessible to all eligible patients regardless of socioeconomic status
Justice in healthcare requires fair and equitable distribution of services; MTM programs must not discriminate based on socioeconomic or other non-clinical factors.
MTM Regulatory Compliance & Ethical Standards 5
A pharmacist's MTM employer instructs staff to bill for Targeted Medication Reviews (TMRs) that were never performed.
Which whistleblower protection law is MOST relevant to a pharmacist who reports this internally and then externally?